Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Frontiers in Immunology|February 3, 2022
Asthma Associated Cytokines Regulate the Expression of SARS-CoV-2 Receptor ACE2 in the Lung Tissue of Asthmatic PatientsFatemeh Saheb Sharif-Askari, Swati Goel, Narjes Saheb Sharif-Askari, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 23, 2013
T cell-derived IL-17 mediates epithelial changes in the airway and drives pulmonary neutrophiliaLaura K Fogli, Mark S Sundrud, Swati Goel, et al.
Blood Advances|September 11, 2020
ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trialStephen T Oh, Moshe Talpaz, Aaron T Gerds, et al.
The Journal of Investigative Dermatology|November 13, 2017
Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell LymphomaMelania H Fanok, Amy Sun, Laura K Fogli, et al.
Annals of the American Thoracic Society|February 27, 2025
The Epidemiology and Impact of Hypoxemia in Sub-Saharan Africa: Prevalence, Practices, and OutcomesInnocent Sulani, Lauren A Onofrey, Letizia Trevisi, et al.
Frontiers in Medicine|May 4, 2023
Oxygen saturation targets for adults with acute hypoxemia in low and lower-middle income countries: a scoping review with analysis of contextual factorsAustin Herbst, Swati Goel, Abi Beane, et al.
Cancer Cell|November 28, 2021
Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancerLauren C Shapiro, Astha Thakkar, Sean T Campbell, et al.
Acta Haematologica|March 5, 2025
ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia VeraJohn Mascarenhas, Prithviraj Bose, Christopher Hillis, et al.
Lancet Regional Health. Americas|June 17, 2026
Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET)Brandi N Reeves, Firas El Chaer, Lynda Foltz, et al.
Blood|August 15, 2018
North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapiesUrvi A Shah, Elaine Y Chung, Orsi Giricz, et al.
Pageof 4